An overview of DGE MRI and its potential applications in brain tumor imaging is provided, including the physical principles underlying the contrast mechanisms and current acquisition strategies and post-processing approaches, including quantification and kinetic modeling.
Abstract
Dynamic glucose-enhanced (DGE) MRI is an emerging imaging technique that provides information on sugar uptake with contributions from delivery (perfusion), transport (membrane permeability), and metabolism in vivo. DGE MRI contrast reflects changes in water magnetization caused by changes in sugar concentration, which can be detected through chemical exchange between water protons and sugar hydroxyl protons. Such contrast can be visualized using chemical exchange-sensitive saturation transfer (CEST), on- and off-resonance spin-lock (CESL), and T 2 relaxation-based approaches. These methods enable the use of biodegradable sugars as contrast agents, which are expected to have fewer side effects than conventional gadolinium-based MRI contrast agents and are more affordable and environmentally friendly. In this review, part of the special issue "New MR imaging techniques in Oncology," we provide an overview of DGE MRI and its potential applications in brain tumor imaging. We introduce the physical principles underlying the contrast mechanisms and summarize current acquisition strategies and post-processing approaches, including quantification and kinetic modeling. Technical challenges such as small signal changes, motion sensitivity, and inhomogeneities in static ( B 0 ) and radiofrequency ( B 1 ) magnetic fields are discussed. Special attention is given to glucose physiology and pharmacokinetics, including administration methods. Throughout, we summarize preclinical and early patient studies in brain tumors and compare DGE MRI with other functional and molecular imaging techniques using MRI and PET. Finally, we discuss future directions for clinical translation, emphasizing the need for standardized protocols and improved acquisition and post-processing strategies.
Increased reliance on anaerobic glycolysis is a hallmark of cancer metabolism that is traditionally used by FDG-PET for lesions and metastases detection. Glucose-based chemical exchange saturation transfer (glucoCEST) MRI offers an alternative, non-radioactive approach for characterizing metabolic changes. In this...
M. Rivlin, Yaniv Yosha, Gil Navon et al.· Scientific Reports· 0 citations
Chemical exchange saturation transfer (CEST) MRI enables sensitive detection of low-concentration metabolites in vivo, but its biological interpretation is limited by the composite nature of the signal, which reflects contributions from multiple cell types. In the brain, these include intracellular metabolites in neuro...
E. Cavallari, V. Bitonto, Morgana Giachello et al.· Angewandte Chemie· 0 citations
The future potential of ASL MRI is seen not only in replacing contrast agents for perfusion assessment but also in providing additional information to the MRI exam, such as BBB integrity or the architecture of the vascular feeders.
Gabriel Hoffmann, M. V. van Osch· MAGMA· 0 citations
Diffusion-weighted imaging (DWI) is a fundamental non-contrast sequence in multiparametric breast magnetic resonance imaging (MRI), measuring water diffusion to assess tissue microstructure. The derived apparent diffusion coefficient (ADC) effectively discriminates between malignant lesions, which typically exhibit low...
Yong Ye, Wen-Wen Shao, Ying Yang· Diagnostic and Interventiona...· 0 citations
Magnetic resonance spectroscopy (MRS) provides non-invasive in vivo assessment of brain tumour metabolism and complements conventional magnetic resonance imaging (MRI) by adding biochemical information beyond structural imaging. This narrative state-of-the-art review summarises current clinical and emerging application...
Maninder Singh, D. Dwivedi, N. Jagannathan· Magnetic Resonance Imaging· 0 citations
It is argued that the field is transitioning from proof-of-principle pharmacodynamic studies toward standardised, biomarker-guided adaptive therapy, and that the principal barriers — technical harmonisation, quantification standards and prospective validation — are now well defined and addressable.
Hao Sun, Xiao-Jun Dong, Jinze Yu et al.· Brazilian Journal of Science· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.